F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 96.28 CNY 20% Market Closed
Market Cap: ¥15.3B

Wall Street
Price Targets

Price Targets Summary
Fujian Cosunter Pharmaceutical Co Ltd

There are no price targets for Fujian Cosunter Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Fujian Cosunter Pharmaceutical Co Ltd Competitors:
Price Targets
SPH
Suburban Propane Partners LP
-12% Downside

Revenue
Forecast

9% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
9% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 11 years the compound annual growth rate for Fujian Cosunter Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 8 years is -4%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Fujian Cosunter Pharmaceutical Co Ltd's stock price target?
Not Available

Fujian Cosunter Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Fujian Cosunter Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-4%

For the last 11 years the compound annual growth rate for Fujian Cosunter Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 8 years is -4%.

Back to Top